{"transactions":[{"id":849507,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:18:25.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":25640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date."}],"balance_after":25640,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":25640},"source":{"system":"sec-edgar","filing":"0001104659-26-026589","document":"tm268588-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026589/tm268588-5_4seq1.xml","form_type":"4"}},{"id":903282,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:14:49.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8450,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000875045-26-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000032/form4.xml","form_type":"4"}},{"id":913187,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":7024,"derivative":{"exercise_price":0,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913186,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":704,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913185,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":789},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913184,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1063,"price":201.18,"value":213854.34,"ownership":{"direct":true},"balance_after":11471.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913183,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12534.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913182,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":207,"price":201.18,"value":41644.26,"ownership":{"direct":true},"balance_after":9023.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913181,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9230.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913180,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":273,"price":201.18,"value":54922.14,"ownership":{"direct":true},"balance_after":8527.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913179,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8800.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":1272571,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:44:59.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001127602-25-004457","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004457/form4.xml","form_type":"4"}},{"id":1272570,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:44:59.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":245,"price":142.54,"value":34922.3,"ownership":{"direct":true},"balance_after":8011.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-004457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004457/form4.xml","form_type":"4"}},{"id":1272569,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:44:59.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":834,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8256.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-004457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004457/form4.xml","form_type":"4"}},{"id":1277540,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1407,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277539,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":789,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":788},"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277538,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":10535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":10535,"derivative":{"exercise_price":0,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":10535},"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277537,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":244,"price":141.35,"value":34489.4,"ownership":{"direct":true},"balance_after":7422.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277536,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7666.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277535,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":232,"price":141.35,"value":32793.2,"ownership":{"direct":true},"balance_after":6963.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1277534,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:48:37.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7195.7483,"source":{"system":"sec-edgar","filing":"0001127602-25-003958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003958/form4.xml","form_type":"4"}},{"id":1279280,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:18:05.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date."}],"balance_after":54343,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-25-010558","document":"tm255864-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010558/tm255864-4_4seq1.xml","form_type":"4"}},{"id":1339681,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-09T21:56:12.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":false,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-12-08","underlying":"Common Stock","underlying_shares":351},"source":{"system":"sec-edgar","filing":"0001127602-24-028860","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224028860/form4.xml","form_type":"4"}},{"id":1339680,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-12-09T21:56:12.000Z","date":"2024-12-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":170,"price":157.78,"value":26822.6,"ownership":{"direct":true},"balance_after":6407.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-028860","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224028860/form4.xml","form_type":"4"}},{"id":1339679,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-12-09T21:56:12.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":true,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6577.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-028860","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224028860/form4.xml","form_type":"4"}},{"id":1573488,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:03:33.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date."}],"balance_after":94009,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-24-035730","document":"tm249071-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035730/tm249071-3_4seq1.xml","form_type":"4"}},{"id":1573487,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:03:33.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":39666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024."}],"balance_after":39666,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":39666},"source":{"system":"sec-edgar","filing":"0001104659-24-035730","document":"tm249071-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035730/tm249071-3_4seq1.xml","form_type":"4"}},{"id":1630986,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":537},"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630985,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":537,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":431},"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630984,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630983,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":127,"price":219.08,"value":27823.16,"ownership":{"direct":true},"balance_after":6226.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630982,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":431,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6353.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630981,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":269,"price":219.08,"value":58932.52,"ownership":{"direct":true},"balance_after":5922.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1630980,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:31:36.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6191.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-006215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006215/form4.xml","form_type":"4"}},{"id":1647460,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T23:01:55.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":834,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001127602-24-004797","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004797/form4.xml","form_type":"4"}},{"id":1647459,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-13T23:01:55.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":245,"price":240.98,"value":59040.1,"ownership":{"direct":true},"balance_after":5277.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-004797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004797/form4.xml","form_type":"4"}},{"id":1647458,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-13T23:01:55.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5522.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-004797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004797/form4.xml","form_type":"4"}},{"id":1652220,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:06:29.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":1577,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":788},"source":{"system":"sec-edgar","filing":"0001127602-24-004306","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004306/form4.xml","form_type":"4"}},{"id":1652219,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:06:29.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":2110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":2110,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":2110},"source":{"system":"sec-edgar","filing":"0001127602-24-004306","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004306/form4.xml","form_type":"4"}},{"id":1652218,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:06:29.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":253,"price":240.3,"value":60795.9,"ownership":{"direct":true},"balance_after":4689.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-004306","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004306/form4.xml","form_type":"4"}},{"id":1652217,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:06:29.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4942.7483,"source":{"system":"sec-edgar","filing":"0001127602-24-004306","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004306/form4.xml","form_type":"4"}},{"id":1665789,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:33:06.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":914,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001127602-24-002808","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002808/form4.xml","form_type":"4"}},{"id":1700430,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-27T02:54:48.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":10461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests immediately prior to the Company's 2024 annual shareholders meeting."}],"balance_after":10461,"derivative":{"exercise_price":2.39,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":10461},"source":{"system":"sec-edgar","filing":"0001104659-23-129369","document":"tm2333426-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129369/tm2333426-6_4seq1.xml","form_type":"4"}},{"id":1715257,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-12T22:02:39.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":false,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021."}],"balance_after":351,"derivative":{"exercise_price":0,"expiration_date":"2024-12-08","underlying":"Common Stock","underlying_shares":351},"source":{"system":"sec-edgar","filing":"0001127602-23-029441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223029441/form4.xml","form_type":"4"}},{"id":1715256,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-12-12T22:02:39.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":170,"price":239.29,"value":40679.3,"ownership":{"direct":true},"balance_after":4154.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-029441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223029441/form4.xml","form_type":"4"}},{"id":1715255,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-12-12T22:02:39.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":true,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4324.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-029441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223029441/form4.xml","form_type":"4"}},{"id":1838166,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-07-05T21:35:35.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vested in three (3) equal annual installments commencing one year after the grant date of 07/01/2020."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":252},"source":{"system":"sec-edgar","filing":"0001127602-23-020236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020236/form4.xml","form_type":"4"}},{"id":1838165,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-05T21:35:35.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":122,"price":284.85,"value":34751.7,"ownership":{"direct":true},"balance_after":3973.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-020236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020236/form4.xml","form_type":"4"}},{"id":1838164,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-05T21:35:35.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4095.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-020236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020236/form4.xml","form_type":"4"}},{"id":2001573,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:01:47.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":968,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":454},"source":{"system":"sec-edgar","filing":"0001127602-23-006519","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006519/form4.xml","form_type":"4"}},{"id":2001572,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:01:47.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":1422,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":512},"source":{"system":"sec-edgar","filing":"0001127602-23-006519","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006519/form4.xml","form_type":"4"}},{"id":2001571,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-22T22:01:47.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":238,"price":278.38,"value":66254.44,"ownership":{"direct":true},"balance_after":3331.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-006519","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006519/form4.xml","form_type":"4"}},{"id":2001570,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-22T22:01:47.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3843.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-006519","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006519/form4.xml","form_type":"4"}},{"id":2017924,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"other","acquired":false,"shares":278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":278},"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017923,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":278,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":228},"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017922,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":1667,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017921,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":261,"price":286.3,"value":74724.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 27, 2023."}],"balance_after":3569.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017920,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":67,"price":286.3,"value":19182.1,"ownership":{"direct":true},"balance_after":3830.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017919,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":228,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3897.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017918,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":262,"price":286.3,"value":75010.6,"ownership":{"direct":true},"balance_after":3669.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2017917,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:37:41.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3931.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-005270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005270/form4.xml","form_type":"4"}},{"id":2023668,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:50:57.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":2365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":2365,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2365},"source":{"system":"sec-edgar","filing":"0001127602-23-004581","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004581/form4.xml","form_type":"4"}},{"id":2044276,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-01-27T23:02:59.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023."}],"balance_after":3098.7483,"source":{"system":"sec-edgar","filing":"0001127602-23-002487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002487/form4.xml","form_type":"4"}},{"id":2090469,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-12T23:04:37.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021."}],"balance_after":702,"derivative":{"exercise_price":0,"expiration_date":"2024-12-08","underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0001127602-22-027340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222027340/form4.xml","form_type":"4"}},{"id":2090468,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-12-12T23:04:37.000Z","date":"2022-12-08","kind":"tax_withholding","acquired":false,"shares":156,"price":289.1,"value":45099.6,"ownership":{"direct":true},"balance_after":2211.7483,"source":{"system":"sec-edgar","filing":"0001127602-22-027340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222027340/form4.xml","form_type":"4"}},{"id":2090467,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-12-12T23:04:37.000Z","date":"2022-12-08","kind":"exercise","acquired":true,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2367.7483,"source":{"system":"sec-edgar","filing":"0001127602-22-027340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222027340/form4.xml","form_type":"4"}},{"id":2213203,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-07-06T23:33:02.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020."}],"balance_after":252,"derivative":{"exercise_price":0,"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":252},"source":{"system":"sec-edgar","filing":"0001127602-22-019021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019021/form4.xml","form_type":"4"}},{"id":2213202,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-07-06T23:33:02.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":74,"price":210.63,"value":15586.62,"ownership":{"direct":true},"balance_after":2017.7483,"source":{"system":"sec-edgar","filing":"0001127602-22-019021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019021/form4.xml","form_type":"4"}},{"id":2213201,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-07-06T23:33:02.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan."}],"balance_after":2091.7483,"source":{"system":"sec-edgar","filing":"0001127602-22-019021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019021/form4.xml","form_type":"4"}},{"id":2296622,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T19:53:15.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":5.11,"expiration_date":"2032-04-13","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-22-046451","document":"tm2212851-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465922046451/tm2212851-6_4seq1.xml","form_type":"4"}},{"id":2380157,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:18:07.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1934,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":570},"source":{"system":"sec-edgar","filing":"0001127602-22-006271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006271/form4.xml","form_type":"4"}},{"id":2380156,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:18:07.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":2504,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":396},"source":{"system":"sec-edgar","filing":"0001127602-22-006271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006271/form4.xml","form_type":"4"}},{"id":2380155,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:18:07.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":117,"price":209.79,"value":24545.43,"ownership":{"direct":true},"balance_after":1737.348,"source":{"system":"sec-edgar","filing":"0001127602-22-006271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006271/form4.xml","form_type":"4"}},{"id":2380154,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:18:07.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":396,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1854.348,"source":{"system":"sec-edgar","filing":"0001127602-22-006271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006271/form4.xml","form_type":"4"}},{"id":2395614,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":506,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":326},"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395613,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":832,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":176},"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395612,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":189},"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395611,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":189,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":99},"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395610,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":85,"price":214.59,"value":18240.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022."}],"balance_after":1458.348,"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395609,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":51,"price":214.59,"value":10944.09,"ownership":{"direct":true},"balance_after":1543.348,"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395608,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":176,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1594.348,"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395607,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":35,"price":214.59,"value":7510.65,"ownership":{"direct":true},"balance_after":1418.348,"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2395606,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:13:42.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1453.348,"source":{"system":"sec-edgar","filing":"0001127602-22-004987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004987/form4.xml","form_type":"4"}},{"id":2399482,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:24:04.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":2500,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001127602-22-004794","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004794/form4.xml","form_type":"4"}},{"id":2429260,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-01-21T21:46:38.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019.  The shares will vest on February 12, 2022."}],"balance_after":1354.348,"source":{"system":"sec-edgar","filing":"0001127602-22-001861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001861/form4.xml","form_type":"4"}},{"id":2477885,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-12-10T21:10:20.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":1052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021."}],"balance_after":1052,"derivative":{"exercise_price":0,"expiration_date":"2024-12-08","underlying":"Common Stock","underlying_shares":1052},"source":{"system":"sec-edgar","filing":"0001127602-21-030720","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030720/form4.xml","form_type":"4"}},{"id":2483085,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":265,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-12-03","expiration_date":"2021-12-03","underlying":"Common Stock","underlying_shares":265},"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483084,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"other","acquired":false,"shares":104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-12-03","underlying":"Common Stock","underlying_shares":104},"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483083,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":74,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":104,"derivative":{"exercise_price":0,"expiration_date":"2021-12-03","underlying":"Common Stock","underlying_shares":74},"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483082,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"tax_withholding","acquired":false,"shares":22,"price":223.92,"value":4926.24,"ownership":{"direct":true},"balance_after":1110.348,"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483081,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"tax_withholding","acquired":false,"shares":78,"price":223.92,"value":17465.76,"ownership":{"direct":true},"balance_after":1132.348,"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483080,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":265,"price":223.92,"value":59338.8,"ownership":{"direct":true},"balance_after":1210.348,"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2483079,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:09:08.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":74,"price":223.92,"value":16570.08,"ownership":{"direct":true},"balance_after":945.348,"source":{"system":"sec-edgar","filing":"0001127602-21-030462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030462/form4.xml","form_type":"4"}},{"id":2646232,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-07-02T20:34:26.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020."}],"balance_after":504,"derivative":{"exercise_price":0,"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":251},"source":{"system":"sec-edgar","filing":"0001127602-21-021266","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221021266/form4.xml","form_type":"4"}},{"id":2646231,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:34:26.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":74,"price":348.92,"value":25820.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 102.902  shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021."}],"balance_after":871.348,"source":{"system":"sec-edgar","filing":"0001127602-21-021266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221021266/form4.xml","form_type":"4"}},{"id":2646230,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:34:26.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":251,"price":348.92,"value":87578.92,"ownership":{"direct":true},"balance_after":945.348,"source":{"system":"sec-edgar","filing":"0001127602-21-021266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221021266/form4.xml","form_type":"4"}},{"id":2676434,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T20:25:47.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":28000,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-21-078786","document":"tm2119245-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465921078786/tm2119245-2_4seq1.xml","form_type":"4"}},{"id":2844481,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:14:54.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2900,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2900},"source":{"system":"sec-edgar","filing":"0001127602-21-006986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006986/form4.xml","form_type":"4"}},{"id":2856354,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:59:50.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1008,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":289},"source":{"system":"sec-edgar","filing":"0001127602-21-006274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006274/form4.xml","form_type":"4"}},{"id":2856353,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:59:50.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1297,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":213},"source":{"system":"sec-edgar","filing":"0001127602-21-006274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006274/form4.xml","form_type":"4"}}],"next_cursor":"2021-02-17T21:59:50.000000Z,2856353"}